Eqvalan (İvermectin) ve equimax (ivermectin+praziquantel)'ın doğal efekte atlarda strongylidae türlerine etkileri

Bu çalışmada Eqvalan® (ivermectin) ve Equimax® (ivermectin + praziquantel)'ın Strongylidae türleri ile doğal enfekte atlarda etkinliklerinin ve etki sürelerinin karşılaştırılması yapılmıştır. Bu amaçla, 20 at iki gruba ayrılmış, birinci gruptaki atlar 0.2 mğ/kg dozda ivermectin (Eqvalan®), ikinci gruptaki atlar ise 0.2 mg/kg ivermectin + 2.5 mg/kg praziquantel (Equimax®) kombinasyonu ile tedavi edilmişlerdir. Tedavi sonrası 3., 5., 7., 9. ve 11. haftalarda alınan dışkı numunelerinde McMaster yöntemiyle gram dışkıdaki yumurta sayıları (EPG) belirlenmiştir. İlaç etkinliği, dışkıda yumurta sayısı azalım testi (FECRT)'ne göre hesaplanmıştır. İki antelmentik de 7 hafta boyunca >%97 etki göstermiş, 9. haftadan itibaren ise EPG değerleri artmaya başlamıştır. Tedavi öncesi ve sonrası yapılan dışkı kültürlerinden elde edilen 3.dönem larvaların Cyathostominae alt familyasına ait olduğu teşhis edilmiştir. İlaç uygulanan hayvanların hiçbirinde yan etki gözlenmemiştir. Sonuç olarak, atları Strongylidae enfeksiyonlarından koruma amaçlı yapılacak Eqvalan® veya Equimax® tedavileri 7 hafta arayla uygulanmalıdır.

Efficacy of eqvalan (ivermectin) and equimax (ivermectin+praziquantel) against strongylidae species in naturally infected horses

The present study was carried out to determine the efficacy rates and the duration of efficacy of two anthelmintic pastes (Eqvalan® and Equimax®) on horses naturally infected by strongyles. Twenty horses were divided into two groups each of 10 animals. Horses in group 1 were treated with 0.2 mg/kg ivermectin (Eqvalan®) and group 2 horses received a combination of 0.2 mg/kg ivermectin + 2.5 mg/kg praziquantel (Equimax®). After treatment, in weeks 3, 5, 7, 9 and 11 individual faecal samples were collected and faecal egg counts (EPG) were determined using a modified McMaster method. The evaluation of drug efficacy was based on faecal egg count reduction test (FECRT). Both Eqvalan® and Equimax® were found to be highly effective (>97%) for a period of 7 weeks. From week 9 onwards, EPG values in both groups were tended to increase. Pre- and post-treatment faecal cultures showed that only small strongyles (Cyathostominae) were present. Adverse reactions to treatments were not observed. It is concluded that treatments of horses either with Eqvalan® or Equimax® for the prevention of strongylosis should be administered with intervals of 7 weeks.

___

1.Akkaya H, Horoz H, Vuruşaner C. Strongylus spp. ve Parascaris equorum ile invaze yarış atlarının (Safkan İngiliz) Febantel (Rintal®) ile tedavisi ve Strongylus larvalarının orantılarının tespiti.T Parazitol Derg 1998;22:303-307.

2.Bauer C, Merkt JC, Janke-Grimm G, Bürger H-J. Prevalence and control of benzimidazole-resistant small strongyles on German thoroughbred studs. Vet Parasitol 1986; 21: 189-203.

3.Bauer C. Praktikum der Veterinärmedizinischen Parasitologie. Ferbersche Universitätsbuchhandlung, Giessen, 1990.

4.Boersema JH, Eysker M, Van der Aar WM. The reappearance of strongyle eggs in the faeces of horses after treatment with moxidectin. Vet Quart 1998; 20: 15-17.

5.chapman mr, french dd, monahan cm, klei tr. Identification and characterization of a pyrantel pamoate resistant cyathostome population. Vet Parasitol 1996; 66: 205-212.

6.Čorba J, PrasliČka J, Várady M, AndraŠko H, HolakovskỲ P. Efficay of Moxidectin 2% Equine Gel and Eqvalan 1% Paste against naturally acquired internal parasite infections in horses. Helminthologia 1995; 32: 215-218.

7.Coşkun ŞZ, Tınar R, Akyol ÇV, Özdemİr T. Atlarda bağırsak nematodları ve Gasterophilus spp.larvalarına Neguvon’un etkisi. T Parazitol Derg 1995;19:140-144.

8.Coşkun ŞZ, Tınar R, Aydın L, Akandır M. Atların Strongylidae enfeksiyonlarında albendazol, febantel, ve luxabendazolün etkisi. Uludağ Üniv Vet Fak Derg 1992; 11:129-134.

9.Demeulenaere D, Vercruysse J, Dorny P, Claerebout E. Comparative studies of ivermectin and moxidectin in the control of naturally acquired cyathostome infections in horses. Vet Rec 1997; 141: 383-386.

10.Duncan JL, Abbott EM, Arundel JH, Eysker M, KleI TR, Krecek RC, Lyons ET, ReInemeyer C, Slocombe JOD. World association for the advancement of veterinary parasitology (WAAVP): second edition of guidelines for evaluating the efficacy of equine anthelmintics. Vet Parasitol 2002; 103: 1-18.

11.Gülanber A, Tüzer E, Gargılı A, Toparlak M, Efil I, Keleş V, Ulutaş M. Efficacy of moxidectin against strongylin nematodes in naturally infected horses. Tr J Vet Anim Sci 1998; 22: 465-466.

12.Herd RP, Gabel AA. Reduced efficacy of anthelmintics in young compared with adult horses. Equine Vet J 1990; 22: 164-169.

13.KleI TR, Rehbein S, Visser M, Langholff WK, Chapman MR, French DD, Hanson P. Re-evaluation of ivermectin efficacy against equine gastrointestinal parasites. Vet Parasitol 2001; 98: 315-320.

14.langrovÁ ı, borovskỲ m, jankovskÁ ı, navrÁtıl j, slavÍk v. The benzimidazole resistance of cyathostomes on five horse farms in the Czech Republic. Helminthologia 2002; 39: 211-216.

15.Lyons ET, tollıver sc, drudge jh. Historical perspective of cyathostomes: prevalence, treatment and control programs. Vet Parasitol 1999; 85: 97-112.

16.MAFF. Manual of Veterinary Parasitological Laboratory Techniques. Reference Book 418. Ministry of Agriculture, Fisheries and Food, HMSO, London, 1986.

17.MartIn-Downum K, YazwInskI T, Tucker C, FIncher M, Ralph J, HamIlton J. Cyathostome fecal egg count trends in horses treated with moxidectin, ivermectin or fenbendazole. Vet Parasitol 2001; 101: 75-79.

18.MercIer P, ChIck B, Alves-Branco F, WhIte CR. Comparative efficacy, persistent effect, and treatment intervals of anthelmintic pastes in naturally infected horses. Vet Parasitol 2001; 99: 29-39.

19.Öge H. Atlarda görülen başlıca helmint enfeksiyonları. FÜ Sağlık Bil Dergisi 2003; 16: 125-131.

20.Parry JM, FIsher MA, GrImshaw WT, Jacobs DE. Anthelmintic dosing intervals for horses: comparison of three chemical groups. Vet Rec 1993; 133: 346-347.

21.Reinemeyer CR, Clymer BC. Comparative efficiency of moxidectin gel or ivermectin paste for cyathostome control in young horses. J Equine Vet Sci 2002; 22: 33-36.

22.Repeta dl, birnbaum n, courtney ch. Anthelmintic resistance on pleasure horse farms in north central Florida. Eq Pract 1993; 15: 8-12.

23.Roelfstra L, Pfister K. Anoplocephala-Infektionen beim Pferd: Epidemiologische Untersuchungen und Bekaempfung mit Praziquantel. Tagung der DVG-Fachgruppe “Parasitologie und Parasitaere Krankheiten”, Leipzig-Germany 20-21, March, 2003, Abstract Book, 48.

24.Rolfe PF, Dawson KL, Holm-MartIn M. Efficacy of moxidectin and other anthelmintics against small strongyles in horses. Aust Vet J 1998; 76: 332-334.

25.Taylor SM, Kenny J. Comparison of moxidectin with ivermectin and pyrantel embonate for reduction of faecal egg counts in horses. Vet Rec 1995; 137: 516-518.

26.Zeeuw GS, Hasslinger MA. Vergleichende Untersuchungen zu Eizahlreduktion und Behandlungsintervall bei Endoparasiten des Pferdes. Prakt Tierarzt 1997; 78 (10): 857-864.